|
|
|
Volumn 13, Issue 6, 1999, Pages 859-875
|
|
Treatment of estrogen deficiency symptoms in women surviving breast cancer. Part 6: Executive summary and consensus statement
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA TOCOPHEROL;
ANTILIPEMIC AGENT;
CLONIDINE;
ESTRADIOL;
RALOXIFENE;
SALCATONIN;
TAMOXIFEN;
VITAMIN D;
BREAST CANCER;
CANCER RECURRENCE;
CANCER SURVIVAL;
CLINICAL PROTOCOL;
COMORBIDITY;
CONFERENCE PAPER;
ESTROGEN DEFICIENCY;
ESTROGEN THERAPY;
FEMALE;
HOT FLUSH;
HUMAN;
HYPERCHOLESTEROLEMIA;
MENOPAUSE;
POSTMENOPAUSE OSTEOPOROSIS;
RECURRENCE RISK;
TREATMENT PLANNING;
BREAST NEOPLASMS;
CARDIOVASCULAR DISEASES;
CLINICAL TRIALS;
ESTROGEN ANTAGONISTS;
ESTROGENS;
ESTROGENS, NON-STEROIDAL;
FEMALE;
HUMANS;
ISOFLAVONES;
MENOPAUSE;
OSTEOPOROSIS;
PHYTOESTROGENS;
PIPERIDINES;
PLANT PREPARATIONS;
RALOXIFENE;
RECEPTORS, ESTROGEN;
SURVIVORS;
|
|
EID: 0033029657
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (16)
|
|
References (0)
|
